Article
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Biochemical pharmacology - 15 Jan 2003
Månsson Emma, Flordal Emma, Liliemark Jan, Spasokoukotskaja Tatiana, Elford Howard, Lagercrantz Svetlana, Eriksson Staffan, Albertioni Freidoun
Abstract excerpt
Mechanisms of acquired resistance to three purine analogues, 2-chloro-2'-deoxyadenosine (cladribine, CdA), 9-beta-D-arabinofuranosyl-2-fluoroadenine (fludarabine, Fara-A), and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (clofarabine, CAFdA) were investigated in a human T-lymphoblastic leukemia cell line (CCRF-CEM). These analogues are pro-drugs and must be activated by deoxycytidine kinase (dCK). The CdA and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
